25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biohit Oyj B
Buy, Hold or Sell?

Let's analyze Biohit Oyj B together

I guess you are interested in Biohit Oyj B. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biohit Oyj B. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biohit Oyj B

I send you an email if I find something interesting about Biohit Oyj B.

Quick analysis of Biohit Oyj B (30 sec.)










What can you expect buying and holding a share of Biohit Oyj B? (30 sec.)

How much money do you get?

How much money do you get?
‚ā¨0.00
When do you have the money?
1 year
How often do you get paid?
10.0%

What is your share worth?

Current worth
‚ā¨0.62
Expected worth in 1 year
‚ā¨1.13
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
‚ā¨0.51
Return On Investment
23.7%

For what price can you sell your share?

Current Price per Share
‚ā¨2.14
Expected price per share
‚ā¨2.09 - ‚ā¨2.25
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Biohit Oyj B (5 min.)




Live pricePrice per Share (EOD)

‚ā¨2.14

Intrinsic Value Per Share

‚ā¨-0.05 - ‚ā¨2.17

Total Value Per Share

‚ā¨0.57 - ‚ā¨2.79

2. Growth of Biohit Oyj B (5 min.)




Is Biohit Oyj B growing?

Current yearPrevious yearGrowGrow %
How rich?$10.1m$8m$2.1m20.7%

How much money is Biohit Oyj B making?

Current yearPrevious yearGrowGrow %
Making money$2m$651.7k$1.3m67.5%
Net Profit Margin14.2%5.5%--

How much money comes from the company's main activities?

3. Financial Health of Biohit Oyj B (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#642 / 982

Most Revenue
#247 / 982

Most Profit
#118 / 982

Most Efficient
#100 / 982
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Biohit Oyj B? (5 min.)

Welcome investor! Biohit Oyj B's management wants to use your money to grow the business. In return you get a share of Biohit Oyj B.

What can you expect buying and holding a share of Biohit Oyj B?

First you should know what it really means to hold a share of Biohit Oyj B. And how you can make/lose money.

Speculation

The Price per Share of Biohit Oyj B is ‚ā¨2.14. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biohit Oyj B.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biohit Oyj B, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ‚ā¨0.62. Based on the TTM, the Book Value Change Per Share is ‚ā¨0.13 per quarter. Based on the YOY, the Book Value Change Per Share is ‚ā¨0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ‚ā¨0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biohit Oyj B.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share‚ā¨% of Price per Share
Usd Eps0.136.2%0.136.2%0.042.0%-0.05-2.6%-0.05-2.4%
Usd Book Value Change Per Share0.146.4%0.146.4%0.010.5%-0.09-4.4%-0.11-5.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.073.5%
Usd Total Gains Per Share0.146.4%0.146.4%0.010.5%-0.09-4.4%-0.03-1.5%
Usd Price Per Share2.04-2.04-1.70-2.41-3.70-
Price to Earnings Ratio15.39-15.39-39.36--2.10--13.51-
Price-to-Total Gains Ratio14.85-14.85-159.44-21.91-43.27-
Price to Book Ratio3.03-3.03-3.17-3.55-4.55-
Price-to-Total Gains Ratio14.85-14.85-159.44-21.91-43.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.320616
Number of shares430
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.14-0.09
Usd Total Gains Per Share0.14-0.09
Gains per Quarter (430 shares)59.18-40.70
Gains per Year (430 shares)236.72-162.80
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
102372270-163-173
204734640-326-336
307107010-488-499
409479380-651-662
50118411750-814-825
60142014120-977-988
70165716490-1140-1151
80189418860-1302-1314
90213121230-1465-1477
100236723600-1628-1640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%3.07.00.030.0%7.013.04.029.2%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.015.00.037.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%1.00.09.010.0%3.00.021.012.5%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.015.00.037.5%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Biohit Oyj B

About Biohit Oyj B

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company's diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.

Fundamental data was last updated by Penke on 2024-07-17 18:23:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is fair priced.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Biohit Oyj B.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit¬†Biohit Oyj B earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • A Net Profit Margin of 14.2%¬†means that¬†€0.14 for each €1¬†in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biohit Oyj B:

  • The MRQ is 14.2%. The company is making a huge profit. +2
  • The TTM is 14.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ14.2%TTM14.2%0.0%
TTM14.2%YOY5.5%+8.7%
TTM14.2%5Y-11.4%+25.5%
5Y-11.4%10Y-12.5%+1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.2%-168.6%+182.8%
TTM14.2%-209.9%+224.1%
YOY5.5%-235.1%+240.6%
5Y-11.4%-390.8%+379.4%
10Y-12.5%-505.1%+492.6%
1.1.2. Return on Assets

Shows how efficient Biohit Oyj B is using its assets to generate profit.

  • Above 5% is considered healthy¬†but always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • 14.3% Return on Assets means that¬†Biohit Oyj B generated¬†€0.14 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biohit Oyj B:

  • The MRQ is 14.3%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 14.3%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ14.3%TTM14.3%0.0%
TTM14.3%YOY5.5%+8.9%
TTM14.3%5Y-6.9%+21.3%
5Y-6.9%10Y-7.2%+0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ14.3%-11.7%+26.0%
TTM14.3%-11.8%+26.1%
YOY5.5%-11.2%+16.7%
5Y-6.9%-13.2%+6.3%
10Y-7.2%-14.6%+7.4%
1.1.3. Return on Equity

Shows how efficient Biohit Oyj B is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • 19.7% Return on Equity means Biohit Oyj B generated €0.20¬†for each¬†€1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biohit Oyj B:

  • The MRQ is 19.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 19.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ19.7%TTM19.7%0.0%
TTM19.7%YOY8.1%+11.6%
TTM19.7%5Y-8.1%+27.8%
5Y-8.1%10Y-8.7%+0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.7%-14.0%+33.7%
TTM19.7%-15.2%+34.9%
YOY8.1%-14.0%+22.1%
5Y-8.1%-18.8%+10.7%
10Y-8.7%-19.3%+10.6%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Biohit Oyj B.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biohit Oyj B is operating .

  • Measures how much profit Biohit Oyj B makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • An Operating Margin of 0.0%¬†means the company generated €0.00 ¬†for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biohit Oyj B:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.9%-7.9%
TTM-5Y-13.0%+13.0%
5Y-13.0%10Y-30.4%+17.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--351.1%+351.1%
TTM--224.3%+224.3%
YOY7.9%-243.1%+251.0%
5Y-13.0%-396.3%+383.3%
10Y-30.4%-510.1%+479.7%
1.2.2. Operating Ratio

Measures how efficient Biohit Oyj B is keeping operating costs low.

  • Below 1 is considered healthy (always compare to¬†Biotechnology industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are €1.24 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biohit Oyj B:

  • The MRQ is 1.241. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.241. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.241TTM1.2410.000
TTM1.241YOY0.897+0.344
TTM1.2415Y1.177+0.064
5Y1.17710Y1.327-0.150
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2413.004-1.763
TTM1.2413.255-2.014
YOY0.8973.484-2.587
5Y1.1775.004-3.827
10Y1.3276.533-5.206
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Biohit Oyj B.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biohit Oyj B is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to¬†Biotechnology industry mean).
  • A Current Ratio of 3.81¬†means the company has €3.81 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biohit Oyj B:

  • The MRQ is 3.806. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.806. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.806TTM3.8060.000
TTM3.806YOY3.459+0.347
TTM3.8065Y4.257-0.450
5Y4.25710Y5.831-1.575
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.8063.793+0.013
TTM3.8064.052-0.246
YOY3.4594.945-1.486
5Y4.2575.990-1.733
10Y5.8316.326-0.495
1.3.2. Quick Ratio

Measures if Biohit Oyj B is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but¬†always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • A Quick Ratio of 2.39¬†means the company can pay off €2.39 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biohit Oyj B:

  • The MRQ is 2.387. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.387. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.387TTM2.3870.000
TTM2.387YOY4.008-1.621
TTM2.3875Y5.440-3.053
5Y5.44010Y8.725-3.285
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3873.186-0.799
TTM2.3873.581-1.194
YOY4.0084.803-0.795
5Y5.4405.922-0.482
10Y8.7256.430+2.295
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Biohit Oyj B.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biohit Oyj B assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare¬†Biohit Oyj B to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.27¬†means that Biohit Oyj B assets are¬†financed with 27.1% credit (debt) and the remaining percentage (100% - 27.1%)¬†is financed by its owners/shareholders.¬†

Let's take a look of the Debt to Asset Ratio trends of Biohit Oyj B:

  • The MRQ is 0.271. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.271. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.2710.000
TTM0.271YOY0.323-0.052
TTM0.2715Y0.238+0.034
5Y0.23810Y0.181+0.057
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2710.330-0.059
TTM0.2710.340-0.069
YOY0.3230.287+0.036
5Y0.2380.368-0.130
10Y0.1810.383-0.202
1.4.2. Debt to Equity Ratio

Measures if Biohit Oyj B is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but¬†always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • A Debt to Equity ratio of 37.2% means that company has €0.37 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biohit Oyj B:

  • The MRQ is 0.372. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.372. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.372TTM0.3720.000
TTM0.372YOY0.477-0.105
TTM0.3725Y0.319+0.053
5Y0.31910Y0.231+0.088
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3720.366+0.006
TTM0.3720.415-0.043
YOY0.4770.369+0.108
5Y0.3190.441-0.122
10Y0.2310.483-0.252
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Biohit Oyj B

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures¬†how much money you pay¬†for each share for¬†every €1 in earnings Biohit Oyj B generates.

  • Above 15 is considered overpriced but¬†always compare¬†Biohit Oyj B to the¬†Biotechnology industry mean.
  • A PE ratio of 15.39 means the investor is paying €15.39¬†for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biohit Oyj B:

  • The EOD is 17.473. Based on the earnings, the company is fair priced.
  • The MRQ is 15.391. Based on the earnings, the company is fair priced.
  • The TTM is 15.391. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.473MRQ15.391+2.082
MRQ15.391TTM15.3910.000
TTM15.391YOY39.356-23.965
TTM15.3915Y-2.100+17.492
5Y-2.10010Y-13.514+11.414
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD17.473-2.610+20.083
MRQ15.391-3.020+18.411
TTM15.391-2.891+18.282
YOY39.356-3.549+42.905
5Y-2.100-6.222+4.122
10Y-13.514-6.322-7.192
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biohit Oyj B:

  • The EOD is 46.204. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 40.699. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 40.699. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD46.204MRQ40.699+5.506
MRQ40.699TTM40.6990.000
TTM40.699YOY13.221+27.477
TTM40.6995Y85.171-44.472
5Y85.17110Y-11.380+96.551
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD46.204-3.139+49.343
MRQ40.699-3.748+44.447
TTM40.699-3.717+44.416
YOY13.221-5.038+18.259
5Y85.171-7.998+93.169
10Y-11.380-8.522-2.858
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biohit Oyj B is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy¬†(always compare to Biotechnology industry mean).
  • A PB ratio of 3.03 means the investor is paying €3.03¬†for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biohit Oyj B:

  • The EOD is 3.441. Based on the equity, the company is fair priced.
  • The MRQ is 3.031. Based on the equity, the company is fair priced.
  • The TTM is 3.031. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.441MRQ3.031+0.410
MRQ3.031TTM3.0310.000
TTM3.031YOY3.171-0.141
TTM3.0315Y3.546-0.515
5Y3.54610Y4.550-1.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4411.928+1.513
MRQ3.0312.247+0.784
TTM3.0312.301+0.730
YOY3.1712.387+0.784
5Y3.5463.674-0.128
10Y4.5504.139+0.411
2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biohit Oyj B compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1270.1270%0.010+1189%-0.087+169%-0.099+178%
Book Value Per Share--0.6220.6220%0.495+26%0.630-1%0.765-19%
Current Ratio--3.8063.8060%3.459+10%4.257-11%5.831-35%
Debt To Asset Ratio--0.2710.2710%0.323-16%0.238+14%0.181+50%
Debt To Equity Ratio--0.3720.3720%0.477-22%0.319+17%0.231+61%
Dividend Per Share----0%-0%-0%0.069-100%
Eps--0.1220.1220%0.040+207%-0.050+141%-0.048+139%
Free Cash Flow Per Share--0.0460.0460%0.119-61%0.027+74%-0.061+232%
Free Cash Flow To Equity Per Share--0.0460.0460%0.106-56%0.018+164%-0.124+369%
Gross Profit Margin--1.0001.0000%0.255+293%1.076-7%1.225-18%
Intrinsic Value_10Y_max--2.172--------
Intrinsic Value_10Y_min---0.054--------
Intrinsic Value_1Y_max--0.082--------
Intrinsic Value_1Y_min---0.048--------
Intrinsic Value_3Y_max--0.350--------
Intrinsic Value_3Y_min---0.107--------
Intrinsic Value_5Y_max--0.742--------
Intrinsic Value_5Y_min---0.127--------
Market Cap26103934.000-9%28489122.80528489122.8050%23652813.020+20%33496263.940-15%50817753.419-44%
Net Profit Margin--0.1420.1420%0.055+158%-0.114+180%-0.125+188%
Operating Margin----0%0.079-100%-0.1300%-0.3040%
Operating Ratio--1.2411.2410%0.897+38%1.177+5%1.327-7%
Pb Ratio3.441+12%3.0313.0310%3.171-4%3.546-15%4.550-33%
Pe Ratio17.473+12%15.39115.3910%39.356-61%-2.100+114%-13.514+188%
Price Per Share2.140+12%1.8851.8850%1.570+20%2.226-15%3.409-45%
Price To Free Cash Flow Ratio46.204+12%40.69940.6990%13.221+208%85.171-52%-11.380+128%
Price To Total Gains Ratio16.861+12%14.85214.8520%159.441-91%21.912-32%43.274-66%
Quick Ratio--2.3872.3870%4.008-40%5.440-56%8.725-73%
Return On Assets--0.1430.1430%0.055+163%-0.069+148%-0.072+150%
Return On Equity--0.1970.1970%0.081+144%-0.081+141%-0.087+144%
Total Gains Per Share--0.1270.1270%0.010+1189%-0.087+169%-0.030+124%
Usd Book Value--10193360.00010193360.0000%8087455.200+26%10289004.080-1%12396101.720-18%
Usd Book Value Change Per Share--0.1380.1380%0.011+1189%-0.095+169%-0.108+178%
Usd Book Value Per Share--0.6740.6740%0.537+26%0.684-1%0.830-19%
Usd Dividend Per Share----0%-0%-0%0.075-100%
Usd Eps--0.1330.1330%0.043+207%-0.055+141%-0.052+139%
Usd Free Cash Flow--759080.000759080.0000%1939991.600-61%435711.920+74%-972381.480+228%
Usd Free Cash Flow Per Share--0.0500.0500%0.129-61%0.029+74%-0.066+232%
Usd Free Cash Flow To Equity Per Share--0.0500.0500%0.115-56%0.019+164%-0.135+369%
Usd Market Cap28307106.030-9%30893604.77030893604.7700%25649110.439+20%36323348.617-15%55106771.808-44%
Usd Price Per Share2.321+12%2.0442.0440%1.703+20%2.414-15%3.697-45%
Usd Profit--2007224.4002007224.4000%651724.400+208%-818938.880+141%-775671.320+139%
Usd Revenue--14179614.40014179614.4000%11875264.400+19%10966103.440+29%9551612.080+48%
Usd Total Gains Per Share--0.1380.1380%0.011+1189%-0.095+169%-0.033+124%
 EOD+2 -6MRQTTM+0 -0YOY+23 -115Y+19 -1410Y+19 -16

3.2. Fundamental Score

Let's check the fundamental score of Biohit Oyj B based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.473
Price to Book Ratio (EOD)Between0-13.441
Net Profit Margin (MRQ)Greater than00.142
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.387
Current Ratio (MRQ)Greater than13.806
Debt to Asset Ratio (MRQ)Less than10.271
Debt to Equity Ratio (MRQ)Less than10.372
Return on Equity (MRQ)Greater than0.150.197
Return on Assets (MRQ)Greater than0.050.143
Total7/10 (70.0%)

3.3. Technical Score

Let's check the technical score of Biohit Oyj B based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5056.832
Ma 20Greater thanMa 502.096
Ma 50Greater thanMa 1002.035
Ma 100Greater thanMa 2002.010
OpenGreater thanClose2.170
Total5/5 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets12,900
Total Liabilities3,500
Total Stockholder Equity9,400
 As reported
Total Liabilities 3,500
Total Stockholder Equity+ 9,400
Total Assets = 12,900

Assets

Total Assets12,900
Total Current Assets11,800
Long-term Assets1,100
Total Current Assets
Cash And Cash Equivalents 3,000
Short-term Investments 3,300
Net Receivables 4,100
Inventory 900
Other Current Assets 500
Total Current Assets  (as reported)11,800
Total Current Assets  (calculated)11,800
+/-0
Long-term Assets
Property Plant Equipment 700
Intangible Assets 183
Long-term Assets Other 100
Long-term Assets  (as reported)1,100
Long-term Assets  (calculated)983
+/- 117

Liabilities & Shareholders' Equity

Total Current Liabilities3,100
Long-term Liabilities400
Total Stockholder Equity9,400
Total Current Liabilities
Accounts payable 500
Other Current Liabilities 1,900
Total Current Liabilities  (as reported)3,100
Total Current Liabilities  (calculated)2,400
+/- 700
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt700
Long-term Liabilities  (as reported)400
Long-term Liabilities  (calculated)700
+/- 300
Total Stockholder Equity
Retained Earnings 3,800
Total Stockholder Equity (as reported)9,400
Total Stockholder Equity (calculated)3,800
+/- 5,600
Other
Capital Stock2,400
Common Stock Shares Outstanding 15,114
Net Invested Capital 9,400
Net Working Capital 8,700
Property Plant and Equipment Gross 700



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
146,417
24,995
22,414
21,875
22,759
27,851
27,320
27,338
27,107
27,399
29,383
71,472
40,007
28,302
14,508
11,728
12,989
18,895
17,887
17,372
10,777
9,613
11,015
12,900
12,90011,0159,61310,77717,37217,88718,89512,98911,72814,50828,30240,00771,47229,38327,39927,10727,33827,32027,85122,75921,87522,41424,995146,417
   > Total Current Assets 
0
0
0
0
10,207
14,852
14,141
14,040
14,359
14,006
15,177
64,216
31,531
24,062
12,011
8,875
10,586
11,354
12,229
13,213
8,299
8,984
9,900
11,800
11,8009,9008,9848,29913,21312,22911,35410,5868,87512,01124,06231,53164,21615,17714,00614,35914,04014,14114,85210,2070000
       Cash And Cash Equivalents 
17,933
2,457
1,374
1,054
1,296
1,745
850
1,109
1,310
1,580
1,659
47,915
248
467
608
723
597
1,339
1,375
1,325
1,038
1,102
2,122
3,000
3,0002,1221,1021,0381,3251,3751,33959772360846724847,9151,6591,5801,3101,1098501,7451,2961,0541,3742,45717,933
       Short-term Investments 
0
0
0
0
-4
2,400
856
923
480
400
500
10,000
30,233
15,239
9,810
6,518
7,134
7,375
8,003
7,996
5,041
4,413
4,105
3,300
3,3004,1054,4135,0417,9968,0037,3757,1346,5189,81015,23930,23310,0005004004809238562,400-40000
       Net Receivables 
30,949
4,837
4,924
5,419
4,977
6,122
6,346
6,385
6,800
6,339
7,779
5,649
422
7,677
774
998
1,991
1,617
1,655
2,902
1,317
2,721
1,140
4,100
4,1001,1402,7211,3172,9021,6551,6171,9919987747,6774225,6497,7796,3396,8006,3856,3466,1224,9775,4194,9244,83730,949
       Other Current Assets 
7,419
2,010
1,735
1,446
5,346
1
6,664
1
480
6,888
1
5,982
606
33
3
-1
1,991
-1
-1
0
0
-2
0
500
5000-200-1-11,991-13336065,98216,88848016,66415,3461,4461,7352,0107,419
   > Long-term Assets 
0
0
0
0
12,552
12,999
13,179
13,298
12,748
13,393
14,206
7,256
8,476
4,240
2,497
2,853
2,403
7,541
5,657
4,159
2,478
629
1,115
1,100
1,1001,1156292,4784,1595,6577,5412,4032,8532,4974,2408,4767,25614,20613,39312,74813,29813,17912,99912,5520000
       Property Plant Equipment 
33,569
6,370
6,425
6,195
6,802
6,860
6,855
7,203
6,452
6,460
6,531
116
432
506
857
782
716
708
557
672
640
420
993
700
7009934206406725577087167828575064321166,5316,4606,4527,2036,8556,8606,8026,1956,4256,37033,569
       Goodwill 
27,477
3,671
3,049
2,638
2,638
2,638
2,638
2,638
2,638
2,638
2,638
0
0
25
0
0
0
0
0
0
0
0
0
0
000000000025002,6382,6382,6382,6382,6382,6382,6382,6383,0493,67127,477
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
1,002
0
596
381
0
1
58
0
0
0
0
0000581038159601,0020000000000000
       Intangible Assets 
30,703
4,247
3,673
3,263
1,160
1,419
1,576
1,494
1,636
2,349
3,177
311
223
1,733
1,609
1,396
1,196
6,763
5,045
3,400
1,763
137
42
183
183421371,7633,4005,0456,7631,1961,3961,6091,7332233113,1772,3491,6361,4941,5761,4191,1603,2633,6734,24730,703
       Long-term Assets Other 
0
0
0
0
-1
2,404
856
923
12
400
499
-1
37,045
15,232
-3
6,520
7,137
1
8,003
7,997
5,041
4,413
4,105
100
1004,1054,4135,0417,9978,00317,1376,520-315,23237,045-1499400129238562,404-10000
> Total Liabilities 
48,394
8,661
7,518
7,774
8,620
13,601
13,905
15,496
14,615
14,650
16,380
18,626
4,515
5,852
1,831
1,418
2,239
1,652
1,995
2,792
2,074
2,313
3,557
3,500
3,5003,5572,3132,0742,7921,9951,6522,2391,4181,8315,8524,51518,62616,38014,65014,61515,49613,90513,6018,6207,7747,5188,66148,394
   > Total Current Liabilities 
24,427
5,234
3,636
4,124
4,063
5,068
6,479
6,172
5,822
10,005
6,980
18,536
4,515
5,644
1,628
1,239
1,822
1,278
1,569
2,377
1,940
2,149
2,862
3,100
3,1002,8622,1491,9402,3771,5691,2781,8221,2391,6285,6444,51518,5366,98010,0055,8226,1726,4795,0684,0634,1243,6365,23424,427
       Short-term Debt 
0
0
0
0
917
901
1,383
866
1,098
5,118
920
4,906
384
384
256
128
0
17
17
228
256
66
257
0
025766256228171701282563843844,9069205,1181,0988661,3839019170000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
384
256
128
0
76
0
0
0
0
0
0
0000007601282563840000000000000
       Accounts payable 
5,771
1,246
837
1,287
1,135
1,676
1,798
1,419
1,321
1,409
1,854
3,045
362
341
529
326
979
414
518
869
612
577
676
500
5006765776128695184149793265293413623,0451,8541,4091,3211,4191,7981,6761,1351,2878371,2465,771
       Other Current Liabilities 
13,406
3,192
1,998
1,909
2,011
2,491
3,106
3,704
3,403
3,478
4,156
6,057
3,769
1
789
785
843
839
1,021
2
-28
54
1,929
1,900
1,9001,92954-2821,02183984378578913,7696,0574,1563,4783,4033,7043,1062,4912,0111,9091,9983,19213,406
   > Long-term Liabilities 
0
0
0
0
4,557
8,533
7,426
9,324
8,793
4,645
9,400
90
0
208
203
179
417
374
426
415
134
164
695
400
4006951641344154263744171792032080909,4004,6458,7939,3247,4268,5334,5570000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
125
155
686
0
068615512500000000000000000000
       Other Liabilities 
0
0
815
680
593
1,181
1,014
981
801
790
818
0
0
209
3
179
417
315
384
356
3
2
2
0
02233563843154171793209008187908019811,0141,18159368081500
> Total Stockholder Equity
97,732
16,223
14,821
14,036
14,139
14,250
13,415
11,842
12,492
12,749
13,003
52,846
35,492
22,450
12,676
10,310
10,750
17,243
15,892
14,579
8,703
7,299
7,457
9,400
9,4007,4577,2998,70314,57915,89217,24310,75010,31012,67622,45035,49252,84613,00312,74912,49211,84213,41514,25014,13914,03614,82116,22397,732
   Common Stock
12,780
2,149
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,199
2,315
2,315
2,348
2,350
2,350
2,350
2,350
2,350
2,350
2,350
2,350
2,350
0
02,3502,3502,3502,3502,3502,3502,3502,3502,3502,3482,3152,3152,1992,1992,1992,1992,1992,1992,1992,1992,1992,14912,780
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,138
5,138
5,138
0
05,1385,1385,13800000000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
13,067
13,137
12,528
12,457
12,210
12,080
12,273
14,291
3,226
2,755
1,887
2,379
4,254
4,634
4,782
5,054
3,885
3,970
3,330
0
03,3303,9703,8855,0544,7824,6344,2542,3791,8872,7553,22614,29112,27312,08012,21012,45712,52813,13713,0670000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.